IOL Chemicals s Pharmaceuticals

IOL Chemicals and Pharmaceuticals Limited Reports Q3 & 9M FY26 Results

IOL Chemicals and Pharmaceuticals reports Q3 FY26 results with revenue growth, higher EBITDA and PBT, and declares an interim dividend for FY26.